GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has commenced the U.S. market release of the Inogen® Rove 4™ Portable Oxygen Concentrator.

加利福尼亚州戈莱塔市——（商业新闻短讯）——Inogen，Inc.（纳斯达克：INGN），一家医疗技术公司，提供用于家庭护理环境的创新呼吸产品，今天宣布已开始在美国市场发布Inogen®Rove 4™便携式氧气浓缩器。

With an additional, fourth flow setting delivering up to 840ml/min of medical grade oxygen, in a lightweight user-friendly design of less than 3 lbs1 and three battery configurations providing up to 5 hours and 45 minutes of operation2, the versatility of Rove 4 empowers patients with choices that may help them with normal activities of daily living..

通过额外的第四流量设置，可提供高达840ml/min的医用级氧气，采用重量不到3磅的轻量级用户友好设计1和三种电池配置，可提供长达5小时45分钟的操作2，Rove 4的多功能性为患者提供了可能有助于他们正常日常生活活动的选择。。

“We are pleased to announce the launch of Rove 4, a meaningful step forward in our intent to serve patients in need of oxygen therapy while allowing them to remain ambulatory,” said Kevin Smith, President and Chief Executive Officer. “This is an important milestone, and we are excited to work with patients and prescribers to deliver the positive impact of Rove 4 technology.”.

总裁兼首席执行官凯文·史密斯（KevinSmith）表示：“我们很高兴宣布推出Rove 4，这是我们在为需要氧气治疗的患者提供服务的同时，让他们保持走动状态的一个有意义的步骤。”。“这是一个重要的里程碑，我们很高兴能与患者和处方医生合作，为Rove 4技术带来积极影响。”。

According to Neil MacIntyre, MD, of Duke University Medical Center, “It is exciting to see the continuing innovation of portable oxygen concentrators to help advance the ambulation of long-term oxygen therapy patients. The Inogen Rove 4 should play a meaningful role on this journey.”

杜克大学医学中心的医学博士尼尔-麦金太尔（Neil MacIntyre）说："看到便携式氧气浓缩器不断创新，帮助推动长期接受氧气治疗的病人的行动能力，我们感到非常兴奋。Inogen Rove 4 将在这一进程中发挥重要作用。

The Rove 4 utilizes Inogen’s patented pulse-dose Intelligent Delivery Technology®3. This technology provides unparalleled triggering sensitivity to quickly detect a breath and deliver oxygen within the first 250 milliseconds of the inspiration, where oxygen has the most effect on lung gas exchange.

Rove 4采用Inogen的专利脉冲剂量智能输送技术®3。这项技术提供了无与伦比的触发灵敏度，可以在吸气的前250毫秒内快速检测呼吸并输送氧气，而氧气对肺部气体交换的影响最大。

Designed for reliability, the Rove 4 offers a best-in-class expected service life of up to 8 years4.

Rove 4的可靠性设计是一流的，预期使用寿命长达8年4。

1 2.9 lbs when used with standard battery.

与标准电池一起使用时为12.9磅。

2 At setting 1.

设置1时为2。

3 Pulse-dose based Intelligent Delivery Technology® ensures that oxygen therapy is delivered efficiently and effectively in all modes of use.

3 Pulse dose based Intelligent Delivery Technology®确保在所有使用模式下都能高效地进行氧疗。

4 When used for less than 8 hours per day.

4每天使用少于8小时。

About Inogen

关于Inogen

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Inogen，Inc.（纳斯达克：INGN）是一家领先的全球医疗技术公司，提供用于家庭护理环境的创新呼吸产品。Inogen通过开发、制造和销售创新的同类最佳便携式制氧机来支持患者呼吸护理，该制氧机用于为患有慢性呼吸系统疾病的患者提供补充性长期氧气治疗。

Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease..

Inogen与患者、处方医生、家庭医疗设备供应商和分销商合作，广泛提供其氧疗产品，使患者有机会保持走动，同时控制疾病的影响。。